PuSH - Publikationsserver des Helmholtz Zentrums München

An exhausted phenotype of TH2 cells is primed by allergen exposure, but not reinforced by allergen-specific immunotherapy.

Allergy 76, 2827-2839 (2021)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
BACKGROUND: Studies show that proallergic TH 2-cells decrease after successful allergen-specific immunotherapy (AIT). It is likely that iatrogenic administration of allergens drives these cells to exhaustion due to chronic T cell receptor stimulation. This study aimed to investigate the exhaustion of T cells in connection with allergenexposure during AIT in mice and two independent patient cohorts. METHODS: OVA-sensitized C57BL/6J mice were challenged and treated with OVA, and the development of exhaustion inlocal and systemic TH 2-cells was analyzed.In patients, the expression of exhaustion-associated surface markers on TH 2-cells was evaluated using flow cytometry in a cross-sectional grass pollen allergy cohort with and without AIT.The treatment effect was further studied in PBMC collected from a prospective long-termAIT cohort. RESULTS: The exhaustion-associated surface markers CTLA-4 and PD-1 were significantly upregulated on TH 2-cells upon OVA aerosol exposure in OVA-allergic compared to non-allergic mice. CTLA-4 and PD-1decreased after AIT, in particular on the surface oflocal lung TH 2-cells. Similarly, CTLA-4 and PD-1 expression were enhanced on TH 2-cells from patients with allergic rhinitis with an even stronger effect in those with concomitant asthma. Using an unbiased Louvain clustering analysis, we discoveredalate-differentiated TH 2 population expressing both markers that decreased during up-dosing but persisted long-term during the maintenance phase. CONCLUSIONS: This study shows that allergen exposure promotes CTLA-4 and PD-1 expression onTH 2-cells, andthat the dynamic change in frequencies of exhausted TH 2-cells exhibits a differential pattern during the up-dosing versus the maintenance phases of AIT.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
13.146
0.000
6
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Ait ; Ctla-4 ; Pd-1 ; T Cell Exhaustion ; Proallergic Th2; T-cells; Immune-responses; Pd-1; Effector; Asthma; Ctla-4; Differentiation; Inflammation; Persistence; Expression
Sprache englisch
Veröffentlichungsjahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0105-4538
e-ISSN 1398-9995
Zeitschrift Allergy
Quellenangaben Band: 76, Heft: 9, Seiten: 2827-2839 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
POF Topic(s) 30202 - Environmental Health
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Allergy
Enabling and Novel Technologies
PSP-Element(e) G-505400-001
G-503800-001
G-505400-005
Förderungen Helmholtz Inflammation Immunology
German Center for Lung Research (DZL)
Scopus ID 85106655439
PubMed ID 33969495
Erfassungsdatum 2021-06-23